Clinical efficiency of bleomycin in oesophageal and skin carcinoma in East Africa.
D000351:Africa, Eastern; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D006801:Humans; D008545:Melanoma / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy*
D009607:Nitrosourea Compounds; D001761:Bleomycin